Performance of bleeding risk scores in dialysis patients

被引:33
|
作者
Ocak, Gurbey [1 ]
Ramspek, Chava [2 ]
Roolunaaker, Maarten B. [1 ]
Blankestijn, Peter J. [1 ]
Verhaar, Marianne C. [1 ]
Bos, Willem Jan W. [3 ]
Dekker, Friedo W. [2 ]
van Diepen, Merel [2 ]
机构
[1] Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands
[2] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands
[3] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands
关键词
ATRIA; dialysis; HASBLED; HEMORR2HAGES; ORBIT; HAS-BLED SCORE; ATRIAL-FIBRILLATION; ANTICOAGULATED PATIENTS; HEMODIALYSIS-PATIENTS; CHA(2)DS(2)-VASC SCORES; MULTIPLE IMPUTATION; WARFARIN INITIATION; PREDICTIVE ABILITY; ISCHEMIC-STROKE; HEMORRHAGE;
D O I
10.1093/ndt/gfy387
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background Bleeding risk scores have been created to identify patients with an increased bleeding risk, which could also be useful in dialysis patients. However, the predictive performances of these bleeding risk scores in dialysis patients are unknown. Therefore, the aim of this study was to validate existing bleeding risk scores in dialysis patients. Methods A cohort of 1745 incident dialysis patients was prospectively followed for 3 years during which bleeding events were registered. We evaluated the discriminative performance of the Hypertension, Abnormal kidney and liver function, Stroke, Bleeding, Labile INR, Elderly and Drugs or alcohol (HASBLED), the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA), the Hepatic or kidney disease, Ethanol abuse, Malignancy, Older age, Reduced platelet count or Reduced platelet function, Hypertension, Anaemia, Genetic factors, Excessive fall risk and Stroke (HEMORR2HAGES) and the Outcomes Registry for Better Informed Treatment (ORBIT) bleeding risk scores by calculating C-statistics with 95% confidence intervals (CI). In addition, calibration was evaluated by comparing predicted and observed risks. Results Of the 1745 dialysis patients, 183 patients had a bleeding event, corresponding to an incidence rate of 5.23/100 person-years. The HASBLED [C-statistic of 0.58 (95% CI 0.54-0.62)], ATRIA [C-statistic of 0.55 (95% CI 0.51-0.60)], HEMORR2HAGES [C-statistic of 0.56 (95% CI 0.52-0.61)] and ORBIT [C-statistic of 0.56 (95% CI 0.52-0.61)] risk scores had poor discriminative performances in dialysis patients. Furthermore, the calibration analyses showed that patients with a low risk of bleeding according to the HASBLED, ATRIA, HEMORR2HAGES and ORBIT bleeding risk scores had higher incidence rates for bleeding in our cohort than predicted. Conclusions The HASBLED, ATRIA, HEMORR2HAGES and ORBIT bleeding risk scores had poor predictive abilities in dialysis patients. Therefore, these bleeding risk scores may not be useful in this population.
引用
收藏
页码:1223 / 1231
页数:9
相关论文
共 50 条
  • [21] Relative performance evaluation of four bleeding risk scores in atrial fibrillation patients. What does the new DOAC score provide?
    Abu-Assi, Emad
    Castro, Andrea Lizancos
    Cespon-Fernandez, Maria
    Gonzalez-Bermudez, Inmaculada
    Roubin, Sergio Raposeiras
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 407
  • [22] Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin
    Burgess, S.
    Crown, N.
    Louzada, M. L.
    Dresser, G.
    Kim, R. B.
    Lazo-Langner, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (09) : 1647 - 1654
  • [23] Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48
    Berg, David D.
    Ruff, Christian T.
    Jarolim, Petr
    Giugliano, Robert P.
    Nordio, Francesco
    Lanz, Hans J.
    Mercuri, Michele F.
    Antman, Elliott M.
    Braunwald, Eugene
    Morrow, David A.
    CIRCULATION, 2019, 139 (06) : 760 - 771
  • [24] Comparison of prediction value of four bleeding risk scores for pulmonary embolism with anticoagulation: A real-world study in Chinese patients
    Zhang, Zhu
    Lei, Jieping
    Zhai, Zhenguo
    Yang, Yuanhua
    Wan, Jun
    Xie, Wanmu
    Wang, Chen
    CLINICAL RESPIRATORY JOURNAL, 2019, 13 (03) : 139 - 147
  • [25] Empiric Anticoagulation Therapy in Hospitalized COVID-19 Patients: An Evaluation of Bleeding Risk Scores Performances in Predicting Bleeding Events
    Abdelrahman, Mona A.
    Ahmed, Aya
    Alanazi, Abdullah S.
    Osama, Hasnaa
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [26] Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
    Proietti, Marco
    Senoo, Keitaro
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    SCIENTIFIC REPORTS, 2016, 6
  • [27] Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation
    Marcucci, Maura
    Nobili, Alessandro
    Tettamanti, Mauro
    Iorio, Alfonso
    Pasina, Luca
    Djade, Codjo D.
    Franchi, Carlotta
    Marengoni, Alessandra
    Salerno, Francesco
    Corrao, Salvatore
    Violi, Francesco
    Mannucci, Pier Mannuccio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (08) : 800 - 806
  • [28] Assessing bleeding risk in patients taking anticoagulants
    Shoeb, Marwa
    Fang, Margaret C.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2013, 35 (03) : 312 - 319
  • [29] Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation
    Guo, Yutao
    Zhu, Hang
    Chen, Yundai
    Lip, Gregory Y. H.
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (02) : 185 - 192
  • [30] Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis
    Wang, Cen
    Yu, Ye
    Zhu, Wengen
    Yu, Jianhua
    Lip, Gregory Y. H.
    Hong, Kui
    ONCOTARGET, 2017, 8 (65) : 109703 - 109711